I characterize myself as a biostatistician with balanced experience in collaboration and methodological research. Many of my statistical contributions have broad applicability and could be adapted to address unique issues in cancer and other diseases. I have been collaborating for over 25 years in the cooperative cancer trial group setting (NCCTG, ACOSOG, CALGB, Alliance) as well as within an NCI-designated cancer center setting (Mayo Cancer Center, Indiana University Cancer Center and Duke Cancer Institute).